Self-reported racial/ethnic discrimination and bronchodilator response in African American youth with asthma. 2017

Sonia Carlson, and Luisa N Borrell, and Celeste Eng, and Myngoc Nguyen, and Shannon Thyne, and Michael A LeNoir, and Nadine Burke-Harris, and Esteban G Burchard, and Neeta Thakur
School of Medicine, University of California, San Francisco, San Francisco, California, United States of America.

OBJECTIVE Asthma is a multifactorial disease composed of endotypes with varying risk profiles and outcomes. African Americans experience a high burden of asthma and of psychosocial stress, including racial discrimination. It is unknown which endotypes of asthma are vulnerable to racial/ethnic discrimination. OBJECTIVE We examined the association between self-reported racial/ethnic discrimination and bronchodilator response (BDR) among African American youth with asthma ages 8 to 21 years (n = 576) and whether this association varies with tumor necrosis factor alpha (TNF-α) level. METHODS Self-reported racial/ethnic discrimination was assessed by a modified Experiences of Discrimination questionnaire as none or any. Using spirometry, BDR was specified as the mean percentage change in forced expiratory volume in one second before and after albuterol administration. TNF-α was specified as high/low levels based on our study population mean. Linear regression was used to examine the association between self-reported racial/ethnic discrimination and BDR adjusted for selected characteristics. An interaction term between TNF-α levels and self-reported racial/ethnic discrimination was tested in the final model. RESULTS Almost half of participants (48.8%) reported racial/ethnic discrimination. The mean percent BDR was higher among participants reporting racial/ethnic discrimination than among those who did not (10.8 versus 8.9, p = 0.006). After adjustment, participants reporting racial/ethnic discrimination had a 1.7 (95% CI: 0.36-3.03) higher BDR mean than those not reporting racial/ethnic discrimination. However, we found heterogeneity of this association according to TNF-α levels (p-interaction = 0.040): Among individuals with TNF-α high level only, we observed a 2.78 higher BDR mean among those reporting racial/ethnic discrimination compared with those not reporting racial/ethnic discrimination (95%CI: 0.79-4.77). CONCLUSIONS We found BDR to be increased in participants reporting racial/ethnic discrimination and this association was limited to African American youth with TNF-α high asthma, an endotype thought to be resistant to traditional asthma medications. These results support screening for racial/ethnic discrimination in those with asthma as it may reclassify disease pathogenesis.

UI MeSH Term Description Entries
D008297 Male Males
D001741 Black or African American A person having origins in any of the black racial groups of Africa (https://www.federalregister.gov/documents/1997/10/30/97-28653/revisions-to-the-standards-for-the classification-of-federal-data-on-race-and-ethnicity). In the United States it is used for classification of federal government data on race and ethnicity. Race and ethnicity terms are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. African American,African Americans,African-American,Afro-American,Afro-Americans,Black Americans,Blacks,Negroes,African-Americans,Negro,Afro American,Afro Americans,American, African,American, Black,Black American
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000420 Albuterol A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. Salbutamol,2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol,Albuterol Sulfate,Proventil,Sultanol,Ventolin
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D012495 San Francisco A city in northern California.

Related Publications

Sonia Carlson, and Luisa N Borrell, and Celeste Eng, and Myngoc Nguyen, and Shannon Thyne, and Michael A LeNoir, and Nadine Burke-Harris, and Esteban G Burchard, and Neeta Thakur
December 2007, Journal of research on adolescence : the official journal of the Society for Research on Adolescence,
Sonia Carlson, and Luisa N Borrell, and Celeste Eng, and Myngoc Nguyen, and Shannon Thyne, and Michael A LeNoir, and Nadine Burke-Harris, and Esteban G Burchard, and Neeta Thakur
April 2009, Applied developmental science,
Sonia Carlson, and Luisa N Borrell, and Celeste Eng, and Myngoc Nguyen, and Shannon Thyne, and Michael A LeNoir, and Nadine Burke-Harris, and Esteban G Burchard, and Neeta Thakur
March 2004, Journal of general internal medicine,
Sonia Carlson, and Luisa N Borrell, and Celeste Eng, and Myngoc Nguyen, and Shannon Thyne, and Michael A LeNoir, and Nadine Burke-Harris, and Esteban G Burchard, and Neeta Thakur
January 2022, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53,
Sonia Carlson, and Luisa N Borrell, and Celeste Eng, and Myngoc Nguyen, and Shannon Thyne, and Michael A LeNoir, and Nadine Burke-Harris, and Esteban G Burchard, and Neeta Thakur
June 2025, Journal of mood and anxiety disorders,
Sonia Carlson, and Luisa N Borrell, and Celeste Eng, and Myngoc Nguyen, and Shannon Thyne, and Michael A LeNoir, and Nadine Burke-Harris, and Esteban G Burchard, and Neeta Thakur
May 2023, Annual review of clinical psychology,
Sonia Carlson, and Luisa N Borrell, and Celeste Eng, and Myngoc Nguyen, and Shannon Thyne, and Michael A LeNoir, and Nadine Burke-Harris, and Esteban G Burchard, and Neeta Thakur
January 2024, Journal of ethnicity in substance abuse,
Sonia Carlson, and Luisa N Borrell, and Celeste Eng, and Myngoc Nguyen, and Shannon Thyne, and Michael A LeNoir, and Nadine Burke-Harris, and Esteban G Burchard, and Neeta Thakur
January 2017, The Journal of black psychology,
Sonia Carlson, and Luisa N Borrell, and Celeste Eng, and Myngoc Nguyen, and Shannon Thyne, and Michael A LeNoir, and Nadine Burke-Harris, and Esteban G Burchard, and Neeta Thakur
April 2016, Cultural diversity & ethnic minority psychology,
Sonia Carlson, and Luisa N Borrell, and Celeste Eng, and Myngoc Nguyen, and Shannon Thyne, and Michael A LeNoir, and Nadine Burke-Harris, and Esteban G Burchard, and Neeta Thakur
March 2012, Developmental psychology,
Copied contents to your clipboard!